Laone Rabatoko
Biographic Data
| ID | 10036116 |
|---|---|
| NAME | Laone Rabatoko |
| GIVEN NAMES | Laone |
| FAMILY NAME | Rabatoko |
| SIGNATURE | RABATOKO L |
| AFFILIATIONS | Botswana Harvard AIDS Institute Partnership |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
High prevalence of undisclosed antiretroviral drug use among individuals initiating HIV treatment in Gaborone, Botswana
Background: Antiretroviral therapy (ART) uptake is critical for evaluating the effectiveness of HIV epidemic control. We evaluated the extent of undisclosed ARV drug use among individuals newly diagnosed and initiating ART in greater Gaborone, Botswana. Methodology: Plasma samples from an ongoing longitudinal cohort study were screened for antiretroviral drug (ARV) traces using the liquid chromatography with tandem mass spectrometry assay. The AR…
No prominent works on this page.
High prevalence of undisclosed antiretroviral drug use among individuals initiating HIV treatment in Gaborone, Botswana
Background: Antiretroviral therapy (ART) uptake is critical for evaluating the effectiveness of HIV epidemic control. We evaluated the extent of undisclosed ARV drug use among individuals newly diagnosed and initiating ART in greater Gaborone, Botswana. Methodology: Plasma samples from an ongoing longitudinal cohort study were screened for antiretroviral drug (ARV) traces using the liquid chromatography with tandem mass spectrometry assay. The AR…
Antiretroviral therapy (1 work) · Atazanavir (1 work) · Dolutegravir (1 work) · Drug (1 work) · Efavirenz (1 work) · HIV/AIDS drug development and treatment (1 work) · HIV/AIDS Research and Interventions (1 work) · Integrase inhibitor (1 work) · Internal Medicine (1 work) · Lopinavir (1 work)